Dopaminergic medication increases reliance on current information in Parkinson's disease

Iris Vilares, Konrad P. Kording

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


The neurotransmitter dopamine is crucial for decision-making under uncertainty, but its computational role is still a subject of intense debate. To test its potential roles, we invited patients with Parkinson's disease (PD), who have less internally generated dopamine, to participate in a visual decision-making task in which uncertainty in both prior and current sensory information was varied. Behaviour during these tasks is often predicted by Bayesian statistics. We found that many aspects of uncertainty processing were conserved in PD patients: They could learn the prior uncertainty and utilize both prior and current sensory information. As predicted by prominent theories, we found that dopaminergic medication influenced the weight given to sensory information. However, as PD patients learned, this bias disappeared. In addition, throughout the experiment the patients exhibited lower sensitivity to current sensory uncertainty compared with age-matched controls. Our results provide empirical evidence for the idea that dopamine levels, which are affected by PD and the drugs used for its treatment, influence the reliance on new information.

Original languageEnglish (US)
Article number0129
JournalNature Human Behaviour
Issue number8
StatePublished - Jul 24 2017
Externally publishedYes

Bibliographical note

Funding Information:
We thank D. Klein, L. Pickering, S. Toledo, C. López-Ortiz and especially T. Simuni for help in recruiting the PD patients. We also thank P. Dayan, H. Fernandes and M. Basso for useful comments on the manuscript. I.V. was supported by the Portuguese Science Foundation, the Gulbenkian Foundation and the Champalimaud Foundation (PhD fellowship SFRH/BD/33272/2007), and, more recently, by a Principal Research Fellowship from the Wellcome Trust to Professor Read Montague. This work was also supported by NIH grant 2R01NS063399 (to K.P.K.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Publisher Copyright:
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.


Dive into the research topics of 'Dopaminergic medication increases reliance on current information in Parkinson's disease'. Together they form a unique fingerprint.

Cite this